Shares of AVITA MED LTD/S ADR (NASDAQ:RCEL) reached a new 52-week high on Wednesday . The company traded as high as $9.75 and last traded at $9.45, with a volume of 560912 shares changing hands. The stock had previously closed at $9.19.
The firm has a market cap of $709.72 million, a price-to-earnings ratio of -24.23 and a beta of 1.28.
AVITA MED LTD/S Company Profile (NASDAQ:RCEL)
Avita Medical Limited operates as a regenerative medicine company in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin.
Featured Article: Google Finance Portfolio
Receive News & Ratings for AVITA MED LTD/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AVITA MED LTD/S and related companies with MarketBeat.com's FREE daily email newsletter.